New Key Statistics Module, Z-Score and F-Score
OTCPK:DMKPQ Key Ratios
| Market Cap $ M | 0.30 |
| Enterprise Value $ M | -0.18 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | -- |
| Price/Sales | 0.03 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 3.00 |
| EPS (TTM) $ | -9.58 |
| Beneish M-Score | 6.07 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | 30.20 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | 0.01 |
| EV-to-EBITDA | 0.01 |
| PEG | -- |
| Shares Outstanding M | 10.09 |
| Net Margin (%) | -614.17 |
| Operating Margin % | -519.31 |
| Pre-tax Margin (%) | -584.39 |
| Quick Ratio | 0.54 |
| Current Ratio | 0.58 |
| ROA % (ttm) | -242.45 |
| ROE % (ttm) | -- |
| ROIC % (ttm) | -520.22 |
| Dividend Yield % | -- |
| Altman Z-Score | -58.66 |
DMKPQ Number of Guru Trades
DMKPQ Volume of Guru Trades
Gurus Latest Trades with OTCPK:DMKPQ
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
OTCPK:DMKPQ is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
DMK Pharmaceuticals Corp Insider Transactions
No Available Data
News about OTCPK:DMKPQ
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers